What is the risk that use of antibiotics in farm animals will result in treatment failure in humans? Different approaches can address this. One approach is to make a risk profile and another to conduct a risk assessment. Use of macrolides in Danish pigs will be used as an example that demonstrates how the conclusion depends on the approach. A risk profile mcludes a description of the hazard and a qualitative assessment of the risk, similar to hazard identification. Accordingly, macrolide-resistant Campylobacter might develop as a result of usage of macrolides in p1g production . This is of concern for human health . because it might reduce the effect of erythromycin , a macrolide used in chi ldren for treatment of Campylobacter infections. A full risk assessment contains an assessment of release , exposure, and consequences related to the unwanted outcome. Release deals with the probability that Campylobacterwill be present m the gut, and how often the isolates found are resistant to macrolides. Exposure relates to the probability of a person being exposed to macrolide-resistant Campylobacter, and here the prevalence in pork -and not live pigs -is of interest. The consequences deal with the outcome of exposure· likelihood of disease/adverse effects. Campylobacter is commonly occurring in the pig gut, and so is macrolideresistance in Campylobacter in pigs. However, the prevalence of Campy/obacter in Dan1sh pork at re tail is negligible because of use of blast-chilling after slaughter. Human campylobactenos1s IS usually self-limiting . One study describes adverse effects related to infection with macrolideresistant Campylobacter-but the effect was severely confounded with age and co-morbidity, and no children got adversely affected. So according to the risk assessment, the risk associated with veterinary use of macrolldes in Danish pigs for the health of humans seemed low. Th1s IS contrary to the resu lt obtained by the risk profile.
Introduction
Veterinary usage of antibiotics might resu lt in development of resistance among zoonot1c bacteria or non-pathogenic microorgamsms. The fear is that treatment failure of humans will occur as a result of infection with zoonotic bacteria originating from e.g. pigs or poultry treated w1th antibiotics. Moreover, transfer of resistance from non-pathogenic microorganisms to human pathogens might occur, and examples of this have been observed. The World Health Organization (WHO) has reservations about veterinary use of macrolides, because of the risk of development of macrolideresistant Campylobacter. In particular, chi ldren are of concern, because macrolides are the drug of choice for treatment of intestinal disorders in children (WHO, 2005) . In line, The US Federal Drug Agency (FDA) considers vetennary usage of macrolides as a nsk for human health (FDA, 2003) . To mitigate th1s risk, usage of antibiotics as growth promoters has gradually been banned w1thin the European Un1on (EU) (Anon., 1998; Anon ., 2003) . In July 1999, the EU suspended four antimicrobial growth promoters; bacitracin , wgin1amycm , sp1ramycin and tylosin (Anon., 1998) In 2006, the Damsh Vetennary & Food Administration decided to redraw macrolldes from the list of drugs recommended for treatment of diarrhea 1n p1gs. The dec1s1on was dnven by a political interest in reducing the antib1ollc consumption per se as well as evidence pointing at a specific risk related to macrolides. The decis1on to leave out macrolides was taken based on a nsk profile, in line with the precautionary principle, which can be used to take preliminary dec1s1ons. A full nsk assessment is then a natural step -to study whether in fact the decision taken IS JUStified or not. Therefore, a risk assessment following mternat1onal guidelines was conducted by the Damsh Meat Association aiming at assessing the risk for human health assoc1ated with usage of ._.. -------------macrolides tn Dantsh ptgs In the followtng it will be demonstrated how the esttmated risk depends on the approach taken: risk profile or quantttattve nsk assessment.
Materials and Methods
lnttlally we tdenttfied macrolide-reststant Campylobacter as the agent of interest based on two cnteria 1) it should be a zoonotic bactenum that causes disease in humans and 2) macrolides should be the drug of chotce for treatment of disease. Data on prevalence of Campylobacter tn beef, pork, poultry meat and humans as well as on macrolide-resistant Campylobacter were obtamed from national and international surveys primarily from 2004 In particular, data from EU surveillance were obtained from the EFSA report (EFSA, 2005) . Moreover, tnformation on antibto!tc consumptton. meat import statistics and consumpttons patterns were obtatned. Information from published papers on the consequences related to human infection with Campylobacterwas also incorporated.
We decided to tnclude pork and poultry m the analysis, whereas we Interpreted pets as carriers of Campylobacter from pork and poultry, because pets often share food with their owners. Beef was ruled out because 11 was an tnstgntficant source of macrolide-resistant Campylobacter.
A nsk profile mcludes a description of the hazard and a qualitative assessment of the risk, similar to hazard tdentificatton A nsk assessment ts an extenston because ts tmplies an evaluation of each of the following steps 1 Hazard identification 2 Release assessment 3 Exposure assessment 4 Consequence assessment 5. Risk esttmatton A quantitattve model was constructed tn the software programme @Risk
Results

Risk proflle
Accordtng to the nsk profile, macrolide-reststant Campylobacter might develop as a result of usage of macrolides tn animal production This is of concern for human health, because 1! mtght reduce the effect of erythromycin, a macrolide used tn children for treatment of Campylobacter mfecttons. In 2004, approximately 131 of macrolides were used for therapeutic treatment tn Denmark (DANMAP, 2004) . Around 92% of thts was used for a productton of 23m fintshers as well as an export of 2m piglets (DANMAP, 2004 , Anon . 2005b . This corresponds to around 0 .5g macrolides per produced ptg (131 x 0 92 /25m ptgs = 0 48g macrolides I pig). The matn part (87%) of the consumption tn ptgs was used for weaners and fintshers. Only around 50kg of macrolides were used in cattle, and here, half of tt was used tn adult cattle and half tn calves <12months of age. In poultry, around 15kg were used (DANMAP, 2004) . This common use selects for development of macrolide-resistance in Campylobacter (Fnmodt-M0IIer and Hammerum, 2004) . Secondly, a Danish study recently published, demonstrated an excess risk of invasiveness or dying among patients tnfected with macrolide-reststant Campylobacter (Helms et al , 2005) . Based on thts tnformation tt was JUdged that use of macrolides for treatment of pigs might lead to development of macrolide-resistant Campylobacter which again constitutes an tncreased nsk for humans
Risk assessment
The release assessment showed that thermophtlic Campylobacter spp are widespread in nature and the prmciple reservoirs are the alimentary tract of wild and domestic btrds and mammals In poultry and cattle, C jejuni is the most commonly found spectes, whereas C colt is most common tn pigs (Stern & Lme 2000) There is a moderate to high prevalence of macrolide-reststant Campylobacter m live ptgs tncludmg Danish pigs presumably as a result of usage of macrolides in ptg production In poultry the macrohde-reststance m Campylobacter ts less common and probably a result of the use of antimicrobial growth promoters (virginiamycin and spiramycin) in broilers in EU before year 2000.
The exposure assessment showed that the prevalence of Campylobacter m pork IS low, and espec1ally low in Danish pork due to blast chilling. In poultry, the proportion of Campy/obacter isolates that are macrolide-resistant is much lower than in pork however; th1s IS counteracted by the h1gh prevalence of Campylobacter found in poultry in general. The exposure model for 2004 data showed that the usage of macrolides in Danish pig production was associated with seven human cases only. The main part of the cases was related to imported meat; pork (83 cases) or poultry meat (74 cases). The distribution between C. ;ejuni and C. coli 1n poultry meat was assumed to be 80·20 in line w1th Nielsen et al (2005), hence 1n domestic produced poultry the proportion or Campylobacter 1solates that is macrolide-resistant IS 0.8 x 0.5% + 0 2 x 3.0% = 1% Sim1larly, for Imported poultry: 0.8 x 3% + 0.2 x 12% = 4 8% In pork, all Isolates were assumed to be C. coli
The consequences assessment showed that in 2004 an incidence of human campylobacteriosis of 68.8 cases per 100,000 inhabitants m Denmark corresponding to 3,724 cases (Anon , 2005a). The disease is usually self-limiting with symptoms lastmg less than seven days Apparently, an excess nsk of Invasiveness and death among patients infected with Campy/obacter has been observed by Helms et al. (2005) . However, the effect of macrolide-resistance found in that study was confounded by age (only old people at risk) and co-morbidity, and non-significant when evaluated for 0 to 30 days of infection (Helms et al., 2005) . In addition, m the study by Helms et al. (2005) no children infected with macrolide-res1stant Campy/obacter had mvas1ve mfect1on or d1ed, and these were the ones that WHO were concerned with. Overall speakmg , the consequences seemed to be negligible for children and adults, and low for old people The crude data showed that pat1ents mfected w1th macrolide-resistant Campylobacter had a probability of 3 4% of expenencmg mvas1ve infection or death (Helms et al. , 2005 
Discussion
The present study demonstrates that the use of the pre-cautionary principle is a preliminary activity that should be utilized when there 1s concern about a given activity/hazard. However, a full risk assessment is also required because 11 m1ght yield a different conclusion about the concerned risk than when only undertaking a nsk-profile. When performmg risk assessments, 1nternat1onal guidelines should be followed . Ideally, the assessment should be subjected to peer-review and an open debate should be held among stakeholders to ensure quality, validity and common understandmg of the nsk assessment. The results of such a nsk assessment constitute the optimal scientific basis of management decisions (Vose et al. , 2001 ).
Conclus ions
The nsk associated with veterinary use of macrolides m Danish pigs for human health because of macrohde-res1stant Campylobacter seems to be negligible to low. A further reduction in the usage of macrolides in Danish pig production will therefore have limited effect on the number of human cases w1th adverse effects due to exposure of Danes to macrolide-res1stant Campylobacter
